Literature DB >> 19579179

Inhibition of neutral endopeptidase 24.11 does not potentiate the improvement in glycemic control obtained with dipeptidyl peptidase-4 inhibition in diabetic Goto-Kakizaki rats.

L Simonsen1, S Pilgaard, R D Carr, A B Kanstrup, J J Holst, C F Deacon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19579179     DOI： 10.1055/s-0029-1225609

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  4 in total

Review 1.  GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.

Authors:  Valeria Guglielmi; Paolo Sbraccia
Journal:  Eat Weight Disord       Date:  2016-12-31       Impact factor: 4.652

2.  Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs.

Authors:  K R Hjøllund; C F Deacon; J J Holst
Journal:  Diabetologia       Date:  2011-05-21       Impact factor: 10.122

Review 3.  Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Authors:  Nathalie Esser; Sakeneh Zraika
Journal:  Diabetologia       Date:  2019-05-14       Impact factor: 10.122

4.  Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.

Authors:  Joshua R Willard; Breanne M Barrow; Sakeneh Zraika
Journal:  Diabetologia       Date:  2016-12-08       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.